Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · JSLL

JSLL

HealthcarePharmaceuticals & Biotechnology₹3684 cr market cap
₹303.25 ▲ +2.33% today As of 19 Nov 2026
52-week low ₹296.3552-week high ₹773.70

-61.7% from the 52-week high · +0.0% above the low

Jeena Sikho Lifecare Ltd. is an ayurveda based healthcare company which provides authentic and good quality ayurvedic products. The company is headquartered in Mohali, Punjab and currently employs 1,226 full-time employees. The company went IPO on 2022-04-19. The firm is engaged in developing health care products and providing ayurvedic healthcare services in India. The company has a portfolio of over a range of ayurvedic products. The Company’s products are manufactured under the brands, including Shuddhi, which provides ayurvedic herbs and products for almost all diseases; Origine Naturspired, which offers beauty and wellness products that help to nourish skin, hair, health, and face naturally. Its products include Shuddhi Kit, Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package and Shuddhi Divya Sanjeevani Anti-Viral. Its Shuddhi Kit offers a complete ayurvedic package that helps the human body in digestion, increases immunity, balances hormones, and helps in detoxification of the body. The firm also conducts various health checkup camps, yoga sessions free of charge to make people aware of their health problems.

The short version. JSLL reported revenue of ₹235 crore for Sep 2026, up 23.7% from a year earlier. Net profit was ₹37 crore (down 37.3% year on year). Return on equity was 47.5% in Mar 2026. Promoter holding was 63.67% in Sep 2026, up 0.14 points over 6 quarters.

1 · The price

How has the stock traded?

JSLL trades 61.7% below its 52-week high and 0.0% above its 52-week low.

Change over period: —

1M-19.9%
3M-40.4%
6M-54.4%
1Y-58.4%

2 · The business

Is it growing?

Sales, year on year+23.7%

Sep 2026 revenue of ₹235 cr.

Profit, year on year-37.3%

Sep 2026 net profit of ₹37 cr.

Net margin15.6%

15.3 pts lower than a year earlier.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025
Revenue235224216222190174
Net profit376645675951
Net margin %15.629.420.930.130.929.4
EPS (₹)2.955.313.635.364.734.13

Annual

FY2026FY2023
Revenue801205
Net profit22234
Net margin %27.716.5
EPS (₹)17.850.0

3 · The quality

How well does it turn capital into profit?

Return on equity was 47.5% in Mar 2026; debt to equity is 0.00.

Profitability · 3 years

Returns and margins

Mar 2026Mar 2025Mar 2023
Return on equity %47.5—26.9
Return on capital %54.5—35.6
EBITDA margin %44.2—23.2
Net margin %27.4—16.3

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR——
Profit CAGR——
Debt to equity0.00
Interest cover24.2x
Current ratio3.25
P/E ratio17.2

4 · The owners

Who holds it, and are they adding?

Promoter holding63.67%

Up 0.14 pts over 6 quarters.

Foreign institutions4.5%

Down 1.49 pts over 6 quarters.

Domestic institutions0.53%

Up 0.35 pts over 6 quarters.

Mutual fund schemes6

+2 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter63.5363.6163.6263.6263.6263.67+0.14
FII5.996.596.316.174.784.5-1.49
DII0.180.150.110.460.360.53+0.35
Public30.329.6529.9629.7631.2331.3+1.0

Mutual fund holdings · Oct 2026

6 schemes hold this stock

4 the month before.

  • Motilal Oswal Nifty Microcap 250 Index Fund0.19% of NAV
  • Bandhan Nifty Total Market Index Fund0.01% of NAV
  • Groww Nifty Total Market Index Fund0.01% of NAV
  • Angel One Nifty Total Market ETF0.01% of NAV
  • Mirae Asset Nifty Total Market Index Fund0.01% of NAV
  • Angel One Nifty Total Market Index Fund0.01% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for JSLL are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about JSLL

What is the JSLL share price?

JSLL (JSLL) last closed at ₹303.25, up 2.33% on the day. Its 52-week range is ₹296.35 to ₹773.70.

What is the market cap of JSLL?

JSLL has a market capitalisation of about ₹3,684 crore. Its price-to-earnings ratio is 17.2.

How are JSLL's latest results?

JSLL reported revenue of ₹235 crore for Sep 2026, up 23.7% from a year earlier. Net profit was ₹37 crore (down 37.3% year on year). Return on equity was 47.5% in Mar 2026. Promoter holding was 63.67% in Sep 2026, up 0.14 points over 6 quarters.

Who owns JSLL?

As of Sep 2026, shareholding was: Promoter 63.67%, FII 4.5%, DII 0.53%, Public 31.3%.

How many mutual funds hold JSLL?

6 mutual fund schemes held JSLL in October 2026. That compares with 4 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 22 Sep 2025 · Final Dividend - Rs. 1.1

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.